Career Search
Explore opportunities with Novartis below.
Notice to applicants for US job openings. Learn More
Showing 2116 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
| Job Title Sort ascending | Business | Location | Site | Date Posted |
|---|---|---|---|---|
| Research Scientist I/II, Oligonucleotide Chemistry Regular, Full time | Research | USA | Cambridge (USA) | Feb 10, 2026 |
| Director, Federal Policy Regular, Full time | Corporate & Division Services | USA | Washington, DC | Feb 10, 2026 |
| Director, Emerging Therapeutic Strategies Regular, Full time | Legal | Switzerland +Alternative Locations | Basel (City) | Feb 10, 2026 |
| Associate Field Operation Manager Regular, Full time | Sales | China | Shanghai (Shanghai) | Feb 10, 2026 |
| Director, Emerging Therapeutic Strategies Regular, Full time | Legal | USA +Alternative Locations | Cambridge (USA) | Feb 10, 2026 |
| Spare Part Coordinator (m/f/d) Temporary (Fixed Term), Full time | Production / Manufacturing | Netherlands | Baarle Nassau | Feb 10, 2026 |
| Digital Content Operation Manager Regular, Full time | Marketing | China | Shanghai (Shanghai) | Feb 10, 2026 |
| Senior eCompliance Program Manager Regular, Full time | Production / Manufacturing | India | Hyderabad (Office) | Feb 10, 2026 |
| Production Support Engineer (m/f/d) Temporary (Fixed Term), Full time | Production / Manufacturing | Netherlands | Baarle Nassau | Feb 10, 2026 |
| Team Leader, Data Enablement – Access & Reimbursement Regular, Full time | General Management | India | Hyderabad (Office) | Feb 10, 2026 |
Pagination
- ‹ Previous page
- 1
- …
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- …
- 212
- › Next page
Adverse Event Reporting
We encourage using the following electronic reporting tool for reporting into the safety database directly: https://www.report.novartis.com/
If electronic reporting tool is not working – please use the following Generic mailbox: [email protected]
CISCO: +20 2 22861000: Press 3 for Adverse Event Reporting